At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 126 enrolled
Drug / intervention
bromfenac ophthalmic solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
In Brief
A Phase 3 clinical trial evaluating bromfenac ophthalmic solution and placebo for Cataract. Completed, enrolled 126 participants across 1 site.
Detailed Summary
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2008
First PostedJun 2008
Primary CompletionNov 2008
TodayJul 2026
First PostedJun 24, 2008
Enrollment StartJun 1, 2008
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 18.0 years ago
Interventions
bromfenac ophthalmic solutiondrug
sterile ophthalmic solution
placebodrug
sterile ophthalmic solution